ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The new facility is expected to significantly improve access to high-quality medical services for patients across Gujarat and neighbouring regions
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
Experts highlighted how robotic-assisted procedures are improving surgical precision, reducing complications, and enabling faster recovery
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
Medical experts point to a growing body of research linking energy drinks to liver injury
The conclave brought together over 1,000 delegates from across India and internationally
The launch coincides with IBS Awareness Month in April
Subscribe To Our Newsletter & Stay Updated